Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nada Maaziz

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Haematologica|May 2, 2024
Red cell mass measurement is still useful for the management of myeloproliferative neoplasms. Comment to "Role of red cell mass evaluation in myeloproliferative neoplasms with splanchnic vein thrombosis and normal hemoglobin value: a study of the France Intergroupe des Syndromes Myeloprolifératifs"Nada Maaziz, François Girodon
Journal of Internal Medicine|July 10, 2024
Olympic Games: When the haematocrit does not fit, the athlete is not always a cheatNada Maaziz, Laurent Martin, Alexandre Marchand, et al.
Methods in Molecular Biology (Clifton, N.J.)|August 30, 2025
Artificial Intelligence and ChromothripsisDavide Callegarin, Nada Maaziz, Anne-Laure Mosca, et al.
British Journal of Haematology|January 2, 2025
EGLN1 mutations in Cis can induce congenital erythrocytosis with thromboses by increasing protein instabilitySerge Carillo, Marine Delamare, Laurent Henry, et al.
British Journal of Haematology|December 4, 2023
Carbon monoxide rebreathing method is a reliable test to evaluate the red cell mass in polycythaemiaNada Maaziz, Marjolaine Georges, Damien Basille, et al.
Biomedical Chromatography : BMC|February 13, 2023
Human plasma ricinine quantification by LC-HRMS after micro-solid-phase elutionPauline Thiebot, Nada Maaziz, Chrystelle Oppon, et al.
Haematologica|March 28, 2024
Benefit of phlebotomy and low-dose aspirin in the prevention of vascular events in patients with <i>EPOR</i> primary familial polycythemia on the island of New CaledoniaLéa Boulnois, Margot Robles, Nada Maaziz, et al.
Drug Testing and Analysis|February 19, 2026
Detection of a Distinct Erythropoietin (EPO) Profile After Isoelectric Focusing in Patients With Familial ErythrocytosisLaurent Martin, Salam Idriss, Nada Maaziz, et al.
Ebiomedicine|May 6, 2026
Biological maturation drives the hepatic-to-renal switch in erythropoietin production at birthSalam Idriss, Laurent Martin, Nada Maaziz, et al.
Genes|May 27, 2023
Germline JAK2 E846D Substitution as the Cause of Erythrocytosis?Nada Maaziz, Céline Garrec, Fabrice Airaud, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Haematologica|May 2, 2024
Red cell mass measurement is still useful for the management of myeloproliferative neoplasms. Comment to "Role of red cell mass evaluation in myeloproliferative neoplasms with splanchnic vein thrombosis and normal hemoglobin value: a study of the France Intergroupe des Syndromes Myeloprolifératifs"Nada Maaziz, François Girodon
Journal of Internal Medicine|July 10, 2024
Olympic Games: When the haematocrit does not fit, the athlete is not always a cheatNada Maaziz, Laurent Martin, Alexandre Marchand, et al.
Methods in Molecular Biology (Clifton, N.J.)|August 30, 2025
Artificial Intelligence and ChromothripsisDavide Callegarin, Nada Maaziz, Anne-Laure Mosca, et al.
British Journal of Haematology|January 2, 2025
EGLN1 mutations in Cis can induce congenital erythrocytosis with thromboses by increasing protein instabilitySerge Carillo, Marine Delamare, Laurent Henry, et al.
British Journal of Haematology|December 4, 2023
Carbon monoxide rebreathing method is a reliable test to evaluate the red cell mass in polycythaemiaNada Maaziz, Marjolaine Georges, Damien Basille, et al.
Biomedical Chromatography : BMC|February 13, 2023
Human plasma ricinine quantification by LC-HRMS after micro-solid-phase elutionPauline Thiebot, Nada Maaziz, Chrystelle Oppon, et al.
Haematologica|March 28, 2024
Benefit of phlebotomy and low-dose aspirin in the prevention of vascular events in patients with <i>EPOR</i> primary familial polycythemia on the island of New CaledoniaLéa Boulnois, Margot Robles, Nada Maaziz, et al.
Drug Testing and Analysis|February 19, 2026
Detection of a Distinct Erythropoietin (EPO) Profile After Isoelectric Focusing in Patients With Familial ErythrocytosisLaurent Martin, Salam Idriss, Nada Maaziz, et al.
Ebiomedicine|May 6, 2026
Biological maturation drives the hepatic-to-renal switch in erythropoietin production at birthSalam Idriss, Laurent Martin, Nada Maaziz, et al.
Genes|May 27, 2023
Germline JAK2 E846D Substitution as the Cause of Erythrocytosis?Nada Maaziz, Céline Garrec, Fabrice Airaud, et al.
Pageof 2